Abstract
Summary
The Dermatological Medicines are concerned with the treatment and prevention of the diseases of the skin, hairs, nails, oral cavity and genitals.
The global market for Dermatological Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dermatological Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dermatological Medicine by region & country, by Type, and by Application.
The Dermatological Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological Medicine.
Market Segmentation
By Company
Johnson and Johnson
GSK
Pfizer
AbbVie
Bayer
Merck
Reckitt Benckiser
Taisho Pharmaceutical
Perrigo
Ikeda Mohando
DermaPharm A/S
LEO Pharma
China Resources Pharmaceutical Group
Chongqing Huapont Pharm Co.
Bright Future Pharmaceutical
Xiuzheng Pharmaceutical Group
China National Pharmaceutical Group
Harbin Letai
Hebei Xinglong Xili Pharmaceutical
Segment by Type:
Anti-infectives
Corticosteroids
Anti-acne
Calcineurin Inhibitors
Retinoids
Others
Segment by Application
Alopecia
Herpes
Psoriasis
Rosacea
Atopic Dermatitis
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Dermatological Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Dermatological Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Dermatological Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Dermatological Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dermatological Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dermatological Medicine by region & country, by Type, and by Application.
The Dermatological Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological Medicine.
Market Segmentation
By Company
Johnson and Johnson
GSK
Pfizer
AbbVie
Bayer
Merck
Reckitt Benckiser
Taisho Pharmaceutical
Perrigo
Ikeda Mohando
DermaPharm A/S
LEO Pharma
China Resources Pharmaceutical Group
Chongqing Huapont Pharm Co.
Bright Future Pharmaceutical
Xiuzheng Pharmaceutical Group
China National Pharmaceutical Group
Harbin Letai
Hebei Xinglong Xili Pharmaceutical
Segment by Type:
Anti-infectives
Corticosteroids
Anti-acne
Calcineurin Inhibitors
Retinoids
Others
Segment by Application
Alopecia
Herpes
Psoriasis
Rosacea
Atopic Dermatitis
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Dermatological Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Dermatological Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Dermatological Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Dermatological Medicine Product Introduction
1.2 Global Dermatological Medicine Market Size Forecast
1.2.1 Global Dermatological Medicine Sales Value (2019-2030)
1.2.2 Global Dermatological Medicine Sales Volume (2019-2030)
1.2.3 Global Dermatological Medicine Sales Price (2019-2030)
1.3 Dermatological Medicine Market Trends & Drivers
1.3.1 Dermatological Medicine Industry Trends
1.3.2 Dermatological Medicine Market Drivers & Opportunity
1.3.3 Dermatological Medicine Market Challenges
1.3.4 Dermatological Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dermatological Medicine Players Revenue Ranking (2023)
2.2 Global Dermatological Medicine Revenue by Company (2019-2024)
2.3 Global Dermatological Medicine Players Sales Volume Ranking (2023)
2.4 Global Dermatological Medicine Sales Volume by Company Players (2019-2024)
2.5 Global Dermatological Medicine Average Price by Company (2019-2024)
2.6 Key Manufacturers Dermatological Medicine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Dermatological Medicine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dermatological Medicine
2.9 Dermatological Medicine Market Competitive Analysis
2.9.1 Dermatological Medicine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Dermatological Medicine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological Medicine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Anti-infectives
3.1.2 Corticosteroids
3.1.3 Anti-acne
3.1.4 Calcineurin Inhibitors
3.1.5 Retinoids
3.1.6 Others
3.2 Global Dermatological Medicine Sales Value by Type
3.2.1 Global Dermatological Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dermatological Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Dermatological Medicine Sales Value, by Type (%) (2019-2030)
3.3 Global Dermatological Medicine Sales Volume by Type
3.3.1 Global Dermatological Medicine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Dermatological Medicine Sales Volume, by Type (2019-2030)
3.3.3 Global Dermatological Medicine Sales Volume, by Type (%) (2019-2030)
3.4 Global Dermatological Medicine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Alopecia
4.1.2 Herpes
4.1.3 Psoriasis
4.1.4 Rosacea
4.1.5 Atopic Dermatitis
4.1.6 Others
4.2 Global Dermatological Medicine Sales Value by Application
4.2.1 Global Dermatological Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dermatological Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Dermatological Medicine Sales Value, by Application (%) (2019-2030)
4.3 Global Dermatological Medicine Sales Volume by Application
4.3.1 Global Dermatological Medicine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Dermatological Medicine Sales Volume, by Application (2019-2030)
4.3.3 Global Dermatological Medicine Sales Volume, by Application (%) (2019-2030)
4.4 Global Dermatological Medicine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Dermatological Medicine Sales Value by Region
5.1.1 Global Dermatological Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dermatological Medicine Sales Value by Region (2019-2024)
5.1.3 Global Dermatological Medicine Sales Value by Region (2025-2030)
5.1.4 Global Dermatological Medicine Sales Value by Region (%), (2019-2030)
5.2 Global Dermatological Medicine Sales Volume by Region
5.2.1 Global Dermatological Medicine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Dermatological Medicine Sales Volume by Region (2019-2024)
5.2.3 Global Dermatological Medicine Sales Volume by Region (2025-2030)
5.2.4 Global Dermatological Medicine Sales Volume by Region (%), (2019-2030)
5.3 Global Dermatological Medicine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Dermatological Medicine Sales Value, 2019-2030
5.4.2 North America Dermatological Medicine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Dermatological Medicine Sales Value, 2019-2030
5.5.2 Europe Dermatological Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Dermatological Medicine Sales Value, 2019-2030
5.6.2 Asia Pacific Dermatological Medicine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Dermatological Medicine Sales Value, 2019-2030
5.7.2 South America Dermatological Medicine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dermatological Medicine Sales Value, 2019-2030
5.8.2 Middle East & Africa Dermatological Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dermatological Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dermatological Medicine Sales Value
6.2.1 Key Countries/Regions Dermatological Medicine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Dermatological Medicine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Dermatological Medicine Sales Value, 2019-2030
6.3.2 United States Dermatological Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dermatological Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dermatological Medicine Sales Value, 2019-2030
6.4.2 Europe Dermatological Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dermatological Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dermatological Medicine Sales Value, 2019-2030
6.5.2 China Dermatological Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dermatological Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dermatological Medicine Sales Value, 2019-2030
6.6.2 Japan Dermatological Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dermatological Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dermatological Medicine Sales Value, 2019-2030
6.7.2 South Korea Dermatological Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dermatological Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dermatological Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Dermatological Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dermatological Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dermatological Medicine Sales Value, 2019-2030
6.9.2 India Dermatological Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dermatological Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson and Johnson
7.1.1 Johnson and Johnson Company Information
7.1.2 Johnson and Johnson Introduction and Business Overview
7.1.3 Johnson and Johnson Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Johnson and Johnson Dermatological Medicine Product Offerings
7.1.5 Johnson and Johnson Recent Development
7.2 GSK
7.2.1 GSK Company Information
7.2.2 GSK Introduction and Business Overview
7.2.3 GSK Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GSK Dermatological Medicine Product Offerings
7.2.5 GSK Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer Dermatological Medicine Product Offerings
7.3.5 Pfizer Recent Development
7.4 AbbVie
7.4.1 AbbVie Company Information
7.4.2 AbbVie Introduction and Business Overview
7.4.3 AbbVie Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 AbbVie Dermatological Medicine Product Offerings
7.4.5 AbbVie Recent Development
7.5 Bayer
7.5.1 Bayer Company Information
7.5.2 Bayer Introduction and Business Overview
7.5.3 Bayer Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bayer Dermatological Medicine Product Offerings
7.5.5 Bayer Recent Development
7.6 Merck
7.6.1 Merck Company Information
7.6.2 Merck Introduction and Business Overview
7.6.3 Merck Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Merck Dermatological Medicine Product Offerings
7.6.5 Merck Recent Development
7.7 Reckitt Benckiser
7.7.1 Reckitt Benckiser Company Information
7.7.2 Reckitt Benckiser Introduction and Business Overview
7.7.3 Reckitt Benckiser Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Reckitt Benckiser Dermatological Medicine Product Offerings
7.7.5 Reckitt Benckiser Recent Development
7.8 Taisho Pharmaceutical
7.8.1 Taisho Pharmaceutical Company Information
7.8.2 Taisho Pharmaceutical Introduction and Business Overview
7.8.3 Taisho Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Taisho Pharmaceutical Dermatological Medicine Product Offerings
7.8.5 Taisho Pharmaceutical Recent Development
7.9 Perrigo
7.9.1 Perrigo Company Information
7.9.2 Perrigo Introduction and Business Overview
7.9.3 Perrigo Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Perrigo Dermatological Medicine Product Offerings
7.9.5 Perrigo Recent Development
7.10 Ikeda Mohando
7.10.1 Ikeda Mohando Company Information
7.10.2 Ikeda Mohando Introduction and Business Overview
7.10.3 Ikeda Mohando Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Ikeda Mohando Dermatological Medicine Product Offerings
7.10.5 Ikeda Mohando Recent Development
7.11 DermaPharm A/S
7.11.1 DermaPharm A/S Company Information
7.11.2 DermaPharm A/S Introduction and Business Overview
7.11.3 DermaPharm A/S Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 DermaPharm A/S Dermatological Medicine Product Offerings
7.11.5 DermaPharm A/S Recent Development
7.12 LEO Pharma
7.12.1 LEO Pharma Company Information
7.12.2 LEO Pharma Introduction and Business Overview
7.12.3 LEO Pharma Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 LEO Pharma Dermatological Medicine Product Offerings
7.12.5 LEO Pharma Recent Development
7.13 China Resources Pharmaceutical Group
7.13.1 China Resources Pharmaceutical Group Company Information
7.13.2 China Resources Pharmaceutical Group Introduction and Business Overview
7.13.3 China Resources Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 China Resources Pharmaceutical Group Dermatological Medicine Product Offerings
7.13.5 China Resources Pharmaceutical Group Recent Development
7.14 Chongqing Huapont Pharm Co.
7.14.1 Chongqing Huapont Pharm Co. Company Information
7.14.2 Chongqing Huapont Pharm Co. Introduction and Business Overview
7.14.3 Chongqing Huapont Pharm Co. Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Chongqing Huapont Pharm Co. Dermatological Medicine Product Offerings
7.14.5 Chongqing Huapont Pharm Co. Recent Development
7.15 Bright Future Pharmaceutical
7.15.1 Bright Future Pharmaceutical Company Information
7.15.2 Bright Future Pharmaceutical Introduction and Business Overview
7.15.3 Bright Future Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Bright Future Pharmaceutical Dermatological Medicine Product Offerings
7.15.5 Bright Future Pharmaceutical Recent Development
7.16 Xiuzheng Pharmaceutical Group
7.16.1 Xiuzheng Pharmaceutical Group Company Information
7.16.2 Xiuzheng Pharmaceutical Group Introduction and Business Overview
7.16.3 Xiuzheng Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Xiuzheng Pharmaceutical Group Dermatological Medicine Product Offerings
7.16.5 Xiuzheng Pharmaceutical Group Recent Development
7.17 China National Pharmaceutical Group
7.17.1 China National Pharmaceutical Group Company Information
7.17.2 China National Pharmaceutical Group Introduction and Business Overview
7.17.3 China National Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 China National Pharmaceutical Group Dermatological Medicine Product Offerings
7.17.5 China National Pharmaceutical Group Recent Development
7.18 Harbin Letai
7.18.1 Harbin Letai Company Information
7.18.2 Harbin Letai Introduction and Business Overview
7.18.3 Harbin Letai Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Harbin Letai Dermatological Medicine Product Offerings
7.18.5 Harbin Letai Recent Development
7.19 Hebei Xinglong Xili Pharmaceutical
7.19.1 Hebei Xinglong Xili Pharmaceutical Company Information
7.19.2 Hebei Xinglong Xili Pharmaceutical Introduction and Business Overview
7.19.3 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product Offerings
7.19.5 Hebei Xinglong Xili Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Dermatological Medicine Industrial Chain
8.2 Dermatological Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dermatological Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Dermatological Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer